AWM
CTXR icon

Argent Wealth Management’s Citius Pharmaceuticals CTXR Stock Holding History

Argent Wealth Management’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$178K Hold
6,578
– – 0.03% 165
2020
Q1 		$113K Hold
6,578
– – 0.02% 157
2019
Q4 		$168K Buy
+6,578
New +$96.3K 0.03% 174

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return

Argent Wealth Management's CTXR Position: Q2 2020 in Review

Argent Wealth Management held its Citius Pharmaceuticals (CTXR) position steady in Q2 2020 at 6,578 shares worth $178K. The position accounts for 0.03% of the portfolio, ranked #165.

Argent Wealth Management first reported a position in CTXR in Q4 2019 and has held it in 3 quarters since. 13 funds tracked by Wall St. Rank hold CTXR as of Q2 2020.

  • Argent Wealth Management held 6,578 shares of Citius Pharmaceuticals worth $178K as of Q2 2020.
  • Argent Wealth Management left its Citius Pharmaceuticals share count unchanged in Q2 2020.
  • Citius Pharmaceuticals made up 0.03% of Argent Wealth Management's portfolio in Q2 2020, its #165 holding.
  • Argent Wealth Management first reported a position in Citius Pharmaceuticals in Q4 2019 and has held it in 3 quarters since.
  • 13 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2020.

Based on Argent Wealth Management's 13F filing for Q2 2020, filed 17 Aug 2020.